ISSUER DOSSIER · CIK 0001517681

Propanc Biopharma, Inc. (PPCB)

Issuer profile1 captured filing nodes

Business context

Core business: healthcare product development and commercialization. Products or assets: drug candidates, therapies or medical-device assets. Commercial model: research, regulatory progression and commercialization.

First captured2026-02-19

Latest filingS-1/A · 2026-02-19

Registration path0 initial filings · 1 amendment

What to watch next

Compare the next amendment against the current filing, then monitor for EFFECT or 424B. Material offering terms can change between amendments.

Latest captured filing: S-1/A · 2026-02-19 · 161 days ago.

Official filing timeline

2026-02-19S-1/A · official filing
Propanc Biopharma, Inc. (PPCB)

Open latest official filing →